PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC) PHENOTYPES AS BIOMARKERS FOR PATIENTS WITH ALZHEIMER’S DISEASE AND/OR MILD COGNITIVE IMPAIRMENT (MCI)
Published in EP Patent, 2022
The present invention relates to a method for identifying whether a mammal suffers from or is likely to suffer from Alzheimer’s disease (AD) and/or a mild cognitive impairment (MCI), using a phenotypic signature as generated using multivariate classification algorithms.
Recommended citation: Fava, Eugenio and Schneider, Anja and Roth, Wera and Dhole, Pranjal and Blersch, Josephine and Denner, Philip. (2024). EP. Patent No.22760676.1 https://patents.justia.com/patent/20240327913